USS Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
31,870
+372
| +1% | +$46.7K | 0.02% | 392 |
|
|
2025
Q1 | $4.31M | Hold |
31,498
| – | – | 0.03% | 358 |
|
|
2024
Q4 | $4.82M | Sell |
31,498
-5,584
| -15% | -$854K | 0.03% | 384 |
|
|
2024
Q3 | $7.18M | Buy |
37,082
+1,340
| +4% | +$260K | 0.05% | 322 |
|
|
2024
Q2 | $8.3M | Buy |
35,742
+1,386
| +4% | +$322K | 0.07% | 250 |
|
|
2024
Q1 | $7.41M | Buy |
34,356
+4,137
| +14% | +$892K | 0.06% | 272 |
|
|
2023
Q4 | $7.82M | Hold |
30,219
| – | – | 0.07% | 243 |
|
|
2023
Q3 | $7.77M | Buy |
30,219
+1,719
| +6% | +$442K | 0.08% | 239 |
|
|
2023
Q2 | $8.12M | Hold |
28,500
| – | – | 0.1% | 230 |
|
|
2023
Q1 | $7.93M | Buy |
28,500
+444
| +2% | +$123K | 0.11% | 218 |
|
|
2022
Q4 | $7.77M | Hold |
28,056
| – | – | 0.11% | 211 |
|
|
2022
Q3 | $7.49M | Sell |
28,056
-8,292
| -23% | -$2.21M | 0.11% | 199 |
|
|
2022
Q2 | $7.42M | Sell |
36,348
-2,732
| -7% | -$557K | 0.07% | 278 |
|
|
2022
Q1 | $8.23M | Buy |
39,080
+5,437
| +16% | +$1.15M | 0.07% | 310 |
|
|
2021
Q4 | $8.07M | Hold |
33,643
| – | – | 0.06% | 321 |
|
|
2021
Q3 | $9.52M | Buy |
33,643
+6,168
| +22% | +$1.75M | 0.08% | 260 |
|
|
2021
Q2 | $9.52M | Hold |
27,475
| – | – | 0.08% | 171 |
|
|
2021
Q1 | $7.69M | Hold |
27,475
| – | – | 0.07% | 189 |
|
|
2020
Q4 | $6.72M | Sell |
27,475
-7,100
| -21% | -$1.74M | 0.06% | 193 |
|
|
2020
Q3 | $9.8M | Hold |
34,575
| – | – | 0.09% | 141 |
|
|
2020
Q2 | $9.24M | Buy |
34,575
+4,797
| +16% | +$1.28M | 0.1% | 142 |
|
|
2020
Q1 | $9.42M | Buy |
29,778
+22,678
| +319% | +$7.17M | 0.13% | 118 |
|
|
2019
Q4 | $2.11M | Buy |
+7,100
| New | +$2.11M | 0.02% | 149 |
|